Conceived and designed the experiments: SiH WQ. Performed the experiments: SiH KO YL MO YS CCL RCN. Analyzed the data: SiH WQ BA AS YN SM. Contributed reagents/materials/analysis tools: SiH WQ YS SS. Wrote the paper: SiH WQ AA SS SM KM.
Massively parallel, tag-based sequencing systems, such as the SOLiD system, hold the promise of revolutionizing the study of whole genome gene expression due to the number of data points that can be generated in a simple and cost-effective manner. We describe the development of a 5′–end transcriptome workflow for the SOLiD system and demonstrate the advantages in sensitivity and dynamic range offered by this tag-based application over traditional approaches for the study of whole genome gene expression. 5′-end transcriptome analysis was used to study whole genome gene expression within a colon cancer cell line, HT-29, treated with the DNA methyltransferase inhibitor, 5-aza-2′-deoxycytidine (5Aza). More than 20 million 25-base 5′-end tags were obtained from untreated and 5Aza-treated cells and matched to sequences within the human genome. Seventy three percent of the mapped unique tags were associated with RefSeq cDNA sequences, corresponding to approximately 14,000 different protein-coding genes in this single cell type. The level of expression of these genes ranged from 0.02 to 4,704 transcripts per cell. The sensitivity of a single sequence run of the SOLiD platform was 100–1,000 fold greater than that observed from 5′end SAGE data generated from the analysis of 70,000 tags obtained by Sanger sequencing. The high-resolution 5′end gene expression profiling presented in this study will not only provide novel insight into the transcriptional machinery but should also serve as a basis for a better understanding of cell biology.
Genome-wide analysis of gene expression in different cell subpopulations provides insights into many aspects of developmental biology and physiology. Although established functional genomic technologies, such as DNA arrays and serial analysis of gene expression (SAGE), can identify coding and noncoding RNA transcripts, identification of genes across the whole genome is still problematic. Most unique transcripts are expressed at low levels
On the other hand, SAGE
Elucidation of the role of epigenetic regulation of the genome will be achieved by a detailed characterization of the gene expression machinery. Epigenetic processes are essential for normal development and cell differentiation in all species
The tag length used in 5′SAGE technology (19 bp) renders it difficult to identify precisely the genome position of some of the sequence tags. We therefore developed a method to improve 5′SAGE by the generation of 27 mer sequence tags combined with massively parallel sequencing.
Total expressed mRNA (b). The frequency denotes the category of expression level as determined by the number of transcript copies per cell. Unique genes represent the total number of unique genes that corresponded to the RefSeq dataset (c). 5 copies = 100 tags/6 million tags, since human cells are predicted to contain 300,000 mRNA molecules. (d) Validation of the 5′SOLiD analysis using qPCR. Comparison of the 5′SOLiD tag profiling gene expression data with qPCR. The mRNAs corresponding to 40 genes in cells treated with 5Aza were quantified using qPCR. The ratio of mRNA abundances in 5Aza-treated versus control cells determined by this method was compared to the corresponding ratios determined using 5′SOLiD data. The logarithmic values of these ratios were plotted. The Y = X line with a slope of 1 is the expected line when both platforms have identical expression patterns.
We conducted 5′-end sequencing of mRNAs isolated from human colon adenocarcinoma HT-29 cells treated the epigenetic agent, 5Aza, a potent inhibitor of DNA methylation. Using the SOLiD platform, we generated approximately 62 million 25 bp reads (
| Sequenced Tags | Used Tags (A) | Mapped Tags (B) | % (B/A) | Unique Tags (C) | % (C/B) | Unique tags in RefSeq TSSs (D) | % (D/C) | |
| Control | 29,231,644 | 16,050,987 | 9,980,657 | 62% | 7,062,060 | 71% | 5,110,167 | 72% |
| 5Aza | 32,629,872 | 19,865,139 | 13,037,914 | 66% | 9,373,606 | 72% | 6,981,749 | 74% |
| Total | 61,861,516 | 35,916,126 | 23,018,571 | 64% | 16,435,666 | 72% | 12,091,916 | 73% |
| Unique Tags (C) | No mismatches (E) | % (E/C) | One mismatch (F) | % (E/C) | Two mismatches (G) | % (E/C) | |
| Control | 7,062,060 | 2,268,809 | 32% | 2,325,304 | 33% | 2,467,947 | 35% |
| 5Aza | 9,373,606 | 3,771,377 | 40% | 2,879,864 | 31% | 2,722,365 | 29% |
| Total | 16,435,666 | 6,040,186 | 36% | 5,205,168 | 32% | 5,190,312 | 32% |
Unique tags were aligned to a position unambiguously. Unique tags in TSSs present numbers of unique tags mapped to the regions within 500 bases from the representative TSSs of genes in the RefSeq database. Unique tags are categorized into three groups according to the number of mismatches in individual alignments.
In order to assess the reproducibility of the system, we compared the unique reads mapping to RefSeq genes isolated from two independent sequence runs from the same library. These data showed that data generated from technical replicates of the 5′SOLiD library were highly reproducible (Pearson's correlation coefficient
We next calculated the number of genes expressed in a single cell type. As human cells contain approximately 300,000 mRNA molecules
| Copy/cell | Cont (Unique genes) | Mass fraction mRNA | 5Aza (Unique genes) | Mass fraction mRNA | ||
| >500 | 68 | 0% | 24% | 65 | 0% | 24% |
| 51–500 | 1016 | 7% | 41% | 1046 | 7% | 41% |
| 6–50 | 5666 | 38% | 30% | 5609 | 39% | 30% |
| 1–5. | 4012 | 27% | 4% | 3913 | 27% | 4% |
| 0.1–<1 | 4151 | 28% | 1% | 3904 | 27% | 1% |
| Total | 14913 | 100% | 14537 | 100% | ||
Frequency denotes the category of expression level analyzed in transcript copies per cell in each librasiry. Unique genes represent a total number of unique genes hit to the RefSeq sequencing. An estimate of about 300,000 transcripts per cell was used to concert the abundances to copies per cell.
To evaluate the dynamic range and sensitivity of 5′SOLiD, we compared the 5′SOLiD library to a 5′SAGE (19 base) library prepared from HT-29 cells treated with 5Aza. The 5′SAGE libraries comprised approximately 70,000 tags (
These data show a scatter plot of unique transcripts identified by SOLiD sequencing (a) and random samples of 5′SOLiD tags (b) 5′SAGE tag sequencing(c) of libraries prepared from RNA isolated from HT29 cells treated with 5Aza. Individual 5′-end tags are associated with the human gene in which the tag originated. In the graph, each dot represents one gene, and its x and y coordinates indicate the numbers of 5′-end tags associated with the gene in each library (a–c). The number represents a comparison of the Pearson Correlation coefficient between two libraries. (d)–(f), MA plots are calculated from the pair of the number of 5′SOLiD tags and the number of 5′SAGE tags that are associated with a gene. X and Y values are translated into A and M values according to the following formulas: A = ½ (log2X+log2Y), M = log2X−log2Y.
| Description | 5′-end SAGE (n) | RefSeq | 5′endSOLiD (n) | ||
| Cont | 5Aza | Cont | 5Aza | ||
| eukaryotic translation elongation factor 2 | 33 | 7 | NM_001961 | 5605 | 4110 |
| cyclin-dependent kinase inhibitor 1A | 0 | 1 | NM_000389 | 34 | 55 |
| cyclin-dependent kinase inhibitor 2A | 0 | 2 | NM_000077 | 172 | 124 |
| cyclin-dependent kinase inhibitor 1B | 0 | 0 | NM_004064 | 61 | 59 |
| cyclin-dependent kinase inhibitor 2B | 0 | 0 | NM_004936 | 27 | 70 |
| cyclin-dependent kinase inhibitor 1C | 0 | 0 | NM_000076 | 6 | 6 |
| cyclin-dependent kinase inhibitor 2C | 0 | 0 | NM_001262 | 124 | 109 |
| cyclin-dependent kinase inhibitor 2D | 0 | 1 | NM_001800 | 319 | 248 |
| cyclin-dependent kinase inhibitor 3 | 1 | 0 | NM_005192 | 477 | 591 |
| cyclin-dependent kinase 2 | 0 | 0 | NM_001798 | 384 | 406 |
| cyclin-dependent kinase 3 | 0 | 0 | NM_001258 | 34 | 24 |
| cyclin-dependent kinase 4 | 7 | 4 | NM_000075 | 1077 | 1155 |
| cyclin-dependent kinase 5 | 0 | 0 | NM_004935 | 998 | 996 |
| cyclin-dependent kinase 6 | 0 | 0 | NM_001259 | 459 | 406 |
| cyclin-dependent kinase 7 | 0 | 1 | NM_001799 | 162 | 118 |
| cyclin-dependent kinase 8 | 0 | 0 | NM_001260 | 78 | 63 |
| cyclin-dependent kinase 9 | 0 | 0 | NM_001261 | 259 | 199 |
| cyclin-dependent kinase 10 | 0 | 1 | NM_052988 | 183 | 161 |
| retinoblastoma 1 | 0 | 0 | NM_000321 | 71 | 59 |
| tumor protein p53 | 0 | 3 | NM_000546 | 1068 | 1260 |
| myc proto-oncogene protein | 0 | 0 | NM_002467 | 337 | 340 |
| MAX protein isoform f | 0 | 0 | NM_197957 | 73 | 76 |
| adenomatosis polyposis coli | 0 | 0 | NM_000038 | 156 | 138 |
| phosphatase and tensin homolog | 0 | 0 | NM_000314 | 245 | 223 |
| matrix metalloproteinase 7 | 7 | 6 | NM_002423 | 4458 | 3800 |
| erbB-2 | 0 | 1 | NM_001005862 | 412 | 349 |
| erbB-3 | 0 | 1 | NM_001982 | 1046 | 851 |
| v-erb-a erythroblastic leukemia viral oncogene | 0 | 0 | NM_001042599 | 171 | 84 |
| wee1 tyrosine kinase | 0 | 0 | NM_003390 | 277 | 204 |
| F-box only protein 5 | 0 | 0 | NM_012177 | 48 | 41 |
| cyclin A | 0 | 1 | NM_001237 | 657 | 617 |
| cyclin B1 | 0 | 0 | NM_031966 | 1144 | 1587 |
| cyclin B2 | 0 | 0 | NM_004701 | 975 | 686 |
| cyclin D1 | 1 | 3 | NM_053056 | 311 | 449 |
| cyclin D2 | 0 | 0 | NM_001759 | 3 | 3 |
| cyclin D3 | 0 | 0 | NM_001760 | 225 | 220 |
| cyclin E1 | 0 | 0 | NM_001238 | 83 | 66 |
| cyclin E2 | 0 | 0 | NM_057749 | 17 | 13 |
| cyclin J | 0 | 0 | NM_019084 | 43 | 44 |
| cyclin J-like | 0 | 0 | NM_024565 | 133 | 141 |
| cyclin M2 | 0 | 0 | NM_017649 | 53 | 58 |
| cyclin M4 | 0 | 0 | NM_020184 | 48 | 56 |
| cyclin N-terminal domain containing 2 | 0 | 0 | NM_024877 | 6 | 11 |
| cyclin T1 | 0 | 0 | NM_001240 | 15 | 14 |
| cyclin Y-like 1 | 0 | 0 | NM_152523 | 32 | 31 |
| cell division cycle 25A | 0 | 0 | NM_001789 | 306 | 348 |
| cell division cycle 25B | 0 | 0 | NM_004358 | 907 | 867 |
| cell division cycle 25C | 0 | 0 | NM_001790 | 177 | 120 |
| jun oncogene | 0 | 0 | NM_002228 | 670 | 626 |
| polo-like kinase | 0 | 1 | NM_005030 | 414 | 612 |
| secreted frizzled-related protein 1 | 0 | 0 | NM_003012 | 6 | 2 |
| secreted frizzled-related protein 5 | 1 | 0 | NM_003015 | 1 | 1 |
| secreted frizzled-related protein 2 precursor | 0 | 0 | NM_003013 | 1 | 0 |
| myeloid cell leukemia sequence 1 | 0 | 0 | NM_021960 | 1106 | 951 |
| cell division cycle associated 3 | 0 | 0 | NM_031299 | 44 | 43 |
| catenin (cadherin-associated protein), beta 1, | 0 | 0 | NM_001098209 | 424 | 499 |
| tumor protein p73 | 0 | 0 | NM_005427 | 25 | 14 |
| cadherin 1, type 1 preproprotein | 1 | 0 | NM_004360 | 1515 | 1428 |
| lymphoid enhancer-binding factor 1 | 0 | 0 | NM_016269 | 21 | 10 |
| glycogen synthase kinase 3 beta | 1 | 0 | NM_002093 | 436 | 489 |
In this table, each number of tags from 5′SAGE, 5′SOLiD was normarized to 40,000 and 6,000,000.
We determined that the expression of 277 genes differed significantly between the control and 5Aza-treated cells, using the criteria of a fold change ≥2 and a Bonferroni adjusted
Genes whose expression was altered by greater than 20 fold in response to exposure of cells to 5Aza relative to the control cells are listed in
We next used the Gene Ontology Consortium database to categorize the function of those highly expressed genes whose expression was altered by greater than a 10 fold change in response to 5Aza treatment (
To confirm the results of the 5′SOLiD analysis, we performed quantitative real-time PCR (qPCR) on forty transcripts identified in the previous section. We observed a good correlation between the changes in gene expression in response to 5Aza treatment detected b
5′SOLiD tags identify the 5′-end of transcripts. Therefore, we analyzed the distribution of 5′-end tags annotated in exons/introns of known transcripts. Although the highest tag density occurs in the canonical position around the 5′-end of well-characterized genes or in the upstream regions of defined TSSs in the databases, some tags were localized to introns, inner exons or proximal to the most 3′ exon (
(b); Correlation of fold change of the number of tags within the promoter+1st exon relative to the number of tags in the inner exon/intron. The solid lines represent a linear regression fit. The slope is 0.79, 0.73 for the control versus 5Aza (intron/promoter+1st exon) or the control versus 5Aza (exon)/promoter+1st exon), respectively. (c) and (d). Analysis of TSS identified by SOLiD sequence tags. (c) Ratio of 5′SOLiD tags from each library to known TSSs and all libraries. (d) Ratio of SOLiD TSSs to known 5′end tags. Horizontal axes shows the distance of 5′SOLiD tags relative to the mRNA start sites in 1,562,911 known TSSs collected from a variety of human tissues in DBTSS database. Distances are shown as the number of upstream and downstream nucleotides. The coverage is given on the y-axis.
To evaluate whether the 5′-end tags within a given gene region are expressed independently, we performed regression analysis of the fold differences between the numbers of tags localized to the promoter+1st exon relative to the number localized to inner exons/introns in the Control and 5Aza -treated libraries. Each linear regression analysis indicated a good fold-change correlation (
We next evaluated the number of 5′SOLiD tags that were represented among the known TSS in the DBTSS database, which contains the largest collection of human TSSs, and conversely we evaluated what fraction of the TSS contained with the DBTSS were represented within the 5′SOLiD TSSs data.
Massively parallel, tag-based sequencing systems, such as the SOLiD system, hold the promise of revolutionizing the study of whole genome gene expression due to the number of data points that can be generated in a simple and cost-effective manner. We describe here the development of a 5′-end sequencing method, 5′ SOLiD, and demonstrate the advantages offered by this tag-based system with regards to sensitivity and dynamic range over traditional approaches to studying whole genome gene expression. Recently, various studies using next generation sequencing to evaluate transcriptional factor binding sites
HT-29 cells were cultured in RPMI1640 or McCoy's 5A medium supplemented with 10% fetal bovine serum. Cells were incubated with 5Aza (Sigma) (500 nM) for 72 h; the culture medium was replaced with fresh medium with 5Aza every 24 h. Total RNA was extracted using RNA-Bee prior to analysis by 5′SAGE and RT-PCR. The quality of total RNA was analyzed using an Agilent 2100 Bioanalyzer. Prior to 5′SAGE analysis and 5′SOLiD, we examined the influence of 5Aza on HT-29 cells using bisulfite-PCR to determine the methylation status of CpG islands in the MAGE-1 promoter. We found decreased methylation in the MAGE1 promoter after 5Aza-treatment in HT-29 cells. This preliminary experiment confirmed that epigenetic changes were induced by 5Aza (data not shown).
5′SAGE libraries were created as previously described
After first-strand synthesis, RNA was degraded in 15 mM NaOH at 65°C for 1 h. cDNA was amplified in a volume of 100 ul by PCR with 16 pmol of 5′ (5′ [biotin]-
Five to ten micrograms of poly(A)+RNA was treated with bacterial alkaline phosphatase (BAP;TaKaRa). The poly(A)+RNA was extracted twice with phenol∶chloroform (1∶1), ethanol precipitated, and treated with tobacco acid pyrophosphatase (TAP). Then an RNA linker containing recognition sites for EcoP15I was ligated using RNA ligase (TaKaRa): a 5′-oligo 1 (
After first-strand synthesis, RNA was degraded in 15 mM NaOH at 65°C for 1 h. cDNA was amplified in a volume of 100 ul by PCR using 16 pmol of 5′ (5′ [biotin]-
PCR products were digested with the EcoP15I type IIS restriction endonuclease (NEB). The digested 5′-terminal cDNA fragments were bound to streptavidin-coated magnetic beads (Dynal, Oslo, Norway). cDNA fragments that bound to the beads were blunted and then directly ligated to the SOLiD linker in a reaction mixture containing T4 DNA ligase in the supplied buffer for 2.5 h at 16°C. The samples were amplified by PCR using the primers:
In the SOLiD Sequencing System, after each cycle of ligation, the color that is detected represents 4 potential two base combinations and the conversion into nucleotide base space is usually done after the sequence is aligned to the reference genome translated into in the colorspace coding. This two base encoding strategy provides higher sequencing accuracy and inherent error checking capability. The details of principles of SOLiD sequencing and advantages of colorspace are summarized at the link below.
We associated a unique tag with a known transcription start site (TSS) registered in the DBTSS (ver5.2,
cDNA was prepared from total RNA using the Applied Biosystems cDNA archive Kit and random primers. Multiple reactions containing 10 ug total RNA per 100 ul reaction volume were performed for each sample following the manufacturer's recommendations. TaqMan gene expression assays were performed using a FAM-labeled MGB probe. Each TaqMan assay was performed in triplicate for each RNA sample. 7.5 ng total cDNA(as total input RNA) in a 15 ml final volume was used for each assay. Assays were performed with 2xUniversal Master on Applied Biosystems 7500 (Foster City, CA) using universal cycling conditions (2 min at 50°C, 10 min at 95°C, followed by 40 rounds of 15 s at 95°C and 1 min at 60°C). G3PDH was chosen as the reference gene.
Comparison of each 5′SOLiD tag was calculated using Z-test statistics
5′SOLiD tags have been deposited at NCBI Short Read Archive under the project accessions SRA002659.
5′SOLiD is highly reproducible.
(0.05 MB PDF)
Click here for additional data file.
Validation of 5′SOLiD by quantitative real-time PCR using TaqMan probes.
(0.09 MB PDF)
Click here for additional data file.
Transcript profile in HT29 treated with 5Aza.
(0.02 MB XLS)
Click here for additional data file.
5′SAGE tag mapping summary
(0.02 MB XLS)
Click here for additional data file.
Differentially expressed genes in cells treated with 5Aza
(0.02 MB XLS)
Click here for additional data file.
Gene Ontology Comparison
(0.02 MB XLS)
Click here for additional data file.
Cost- and time-benefit analysis of 5′SOLiD, 5′SAGE and SAGE
(0.03 MB XLS)
Click here for additional data file.
We thank M. Inagaki, H. Hanaoka, D. Ito, Y. Kasai, K. Harukawa, and Y. Hodo for technical assistance.